1. Tokars JI, Olsen SJ, Reed C. Seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis. 2018;66(10):1511-1518.

2. Tejada-Vera B, Bastian BA, Curtin SC. Deaths: leading causes for 2023. Natl Vital Stat Rep. 2025;74(10):1-114.

3. Centers for Disease Control and Prevention. Preliminary Estimated Flu Disease Burden 2023-2024 Flu Season. Available at https://www.cdc.gov/flu-burden/php/data-vis/2023-2024.html. Last accessed November 18, 2025.

4. Atkinson W, Hamborsky J, Wolfe C (eds). Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Public Health Foundation; 2015.

5. Putri W, Muscatello D, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960-3966.

6. Mao L, Yang Y, Qiu Y, Yang Y. Annual economic impacts of seasonal influenza on U.S. counties: spatial heterogeneity and patterns. Int J Health Geographics. 2012;11:16.

7. World Health Organization. Influenza: Are We Ready? Available at https://www.who.int/news-room/spotlight/influenza-are-we-ready. Last accessed November 18, 2025.

8. Centers for Disease Control and Prevention. Preliminary Estimated Flu Disease Burden 2024-2025. Available at https://www.cdc.gov/flu-burden/php/data-vis/2024-2025.html. Last accessed November 18, 2025.

9. Reuters. Fact Check: Studies Do Show Face Masks and Lockdowns Slow the Spread of COVID-19. Available at https://www.reuters.com/article/uk-factcheck-masks-lockdowns-covid-idUSKCN2AT3JQ. Last accessed November 18, 2025.

10. Centers for Disease Control and Prevention. Preliminary Estimated Flu Disease Burden 2020–2021 Flu Season. Available at https://www.cdc.gov/flu-burden/php/data-vis/2020-2021.html. Last accessed November 18, 2025.

11. Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2025-26 influenza season. MMWR. 2025;74(32):500-507.

12. Olsen C. Influenza: Pigs, People and Public Health. Available at https://www.montanahelp.org/2004_NPB_swine_flu_factsheet.pdf. Last accessed November 18, 2025.

13. National Institutes of Health. Interregional Spread of Influenza through United States Described by Virus Type, Size of Populations and Commuting Rates and Distance. Available at https://www.nih.gov/news-events/news-releases/interregional-spread-influenza-through-united-states-described-virus-type-size-population-commuting-rates-distance. Last accessed November 18, 2025.

14. Centers for Disease Control and Prevention. Similarities and Differences Between Flu and COVID-19. Available at https://www.cdc.gov/flu/about/flu-vs-covid19.html. Last accessed November 18, 2025.

15. Bowser A. Serious Influenza Complications Common in Children. Available at https://www.medscape.com/viewarticle/474175. Last accessed November 18, 2025.

16. Bryan CS. Infectious Diseases in Primary Care. Philadelphia, PA: W.B. Saunders; 2002.

17. Centers for Disease Control and Prevention. About Influenza. Available at https://www.cdc.gov/flu/about/index.html. Last accessed November 18, 2025.

18. Centers for Disease Control and Prevention. About Influenza. Available at https://www.cdc.gov/flu/about. Last accessed November 18, 2025.

19. Centers for Disease Control and Prevention. Information on Rapid Molecular Assays, RT-PCR, and Other Molecular Assays for Diagnosis of Influenza Virus Infection. Available at https://www.cdc.gov/flu/hcp/testing-methods/molecular-assays.html. Last accessed November 18, 2025.

20. Centers for Disease Control and Prevention. Rapid Influenza Diagnostic Tests (RIDTs). Available at https://www.cdc.gov/flu/hcp/testing-methods/table-ridt.html. Last accessed November 18, 2025.

21. Centers for Disease Control and Prevention. Notice to readers: considerations for distinguishing influenza-like illness from inhalational anthrax. MMWR. 2001;50(44):984-986.

22. Centers for Disease Control and Prevention. Laboratory Information for Collection of Respiratory Specimens for Influenza Virus Testing. Available at https://www.cdc.gov/flu/hcp/info-collection/index.html. Last accessed November 18, 2025.

23. Centers for Disease Control and Prevention. COVID: Variants and Genomic Surveillance. Available at https://www.cdc.gov/covid/php/variants/variants-and-genomic-surveillance.html. Last accessed November 18, 2025.

24. Reinhart K, Huang S, Kniss K, Reed C, Budd A. Influenza-associated pediatric deatths – United States, 2024-25 influenza season. MMWR. 2025;74(36):565-569.

25. Rogawski E, McGrath L, Vielot N, Westreich D. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2014;100(6):517-518.

26. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology. 1993;43(6):1173-1180.

27. Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism: a review. J Neural Transm. 1998;105(6-7):645-676.

28. Pahwa R, Koller WC. Defining Parkinson's disease and parkinsonianism. In: Ellenberg JH, Keller WC, Langston JW (eds). Etiology of Parkinson's Disease. New York, NY: Marcel Dekker; 1995: 1-54.

29. Reid AH, McCall S, Henry JM, Taubenberger JK. Experimenting on the past: the enigma of von Economo's encephalitis lethargica.J Neuropathol Exp Neurol. 2001;60(7):663-670.

30. Brydak LB. Neurological complication of influenza infections. Przegl Epidemiol. 2002;56(Suppl 1):16-30.

31. Takahashi M, Yamada T. A possible role of influenza A virus infection for Parkinson's disease. Adv Neurol. 2001;86:91-104.

32. Centers for Disease Control and Prevention. Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (Fluzone high-dose) and guidance for use—United States, 2010. MMWR. 2010;59(16):485-486.

33. Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2025-26 influenza season. MMWR. 2025;74(32):500-507.

34. National Center for Health Statistics. Influenza. Available at https://www.cdc.gov/nchs/fastats/flu.htm. Last accessed November 18, 2025.

35. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR. 2007;56(RR6):1-54.

36. Centers for Disease Control and Prevention. Influenza Vaccine Safety Considerations During Pregnancy or While Breastfeeding. Available at https://www.cdc.gov/flu/hcp/vax-summary/vaccine-safety-pregnant.html#. Last accessed November 18, 2025.

37. Thompson MG, Kwong JC, Regan AK, et al. Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016. Clin Infect Dis. 2019;68(9):1444-1453.

38. Drugs.com. Fluzone Quadrivalent: Package Insert/Prescribing Information. Available at https://www.drugs.com/pro/fluzone-quadrivalent.html. Last accessed November 18, 2025.

39. Mazunder B, Almoord D, Park K, Crimmins EM, Finch CE. Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease. J Dev Orig Health Dis. 2010;1(1):26-34.

40. Donahue JG, Kieke BA, King JP, et al. Inactivated influeza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15. Vaccine. 2019;37(44):6673-6681.

41. Panagiotakopoulos L, McCarthy NL, Tepper NK, et al. Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. Obstet Gynecol. 2020;136(6):1086-1094.

42. Centers for Disease Control and Prevention. Vaccines for Children Program. Available at https://www.cdc.gov/vaccines-for-children/about/index.html. Last accessed November 18, 2025.

43. Centers for Disease Control and Prevention. Child and Adolescent Immunization Schedule by Age (Addendum Updated August 7, 2025). Available at https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html. Last accessed November 18, 2025.

44. Centers for Disease Control and Prevention. Who Needs a Flu Vaccine. Available at https://www.cdc.gov/flu/vaccines/vaccinations.html. Last accessed November 18, 2025.

45. Centers for Disease Control and Prevention. Influenza-associated pediatric deaths - United States, 2024-25 Influenza Season. MMWR. 2025;74(36):565-569.

46. Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010). Clin Infect Dis. 2011;52(Suppl 1):S75-S82.

47. Centers for Disease Control and Prevention. Flu Prevention: Information for Travelers. Available at https://www.cdc.gov/flu/travelersfacts/index.html#. Last accessed November 18, 2025.

48. Centers for Disease Control and Prevention. Recombinant Influenza (Flu) Vaccine. Available at https://www.cdc.gov/flu/vaccine-types/flublok-vaccine.html. Last accessed November 18, 2025.

49. Centers for Disease Control and Prevention. Influenza and Breastfeeding. Available at https://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/flu.html#. Last accessed November 18, 2025.

50. Brown D. For health officials flu shot is an annual gamble. Washington Post. January 12, 2004:A3. Available at https://www.washingtonpost.com/archive/politics/2004/01/12/for-health-officials-flu-shot-is-an-annual-gamble/afc8fb2e-fffa-4867-a46c-1b3449196fc5/. Last accessed November 18, 2025.

51. Bartlett J. Infectious Diseases: February 15, 2004. Available at https://www.medscape.com/viewarticle/467518. Last accessed November 18, 2025.

52. Centers for Disease Control and Prevention. How Influenza Vaccines Are Made. Available at https://www.cdc.gov/flu/vaccine-process/index.html. Last accessed November 18, 2025.

53. Centers for Disease Control and Prevention. 2024-2025 Influenza Season Vaccine Supply. Available at https://www.cdc.gov/flu/hcp/vaccine-supply/2024-2025.html. Last accessed November 18, 2025.

54. Centers for Disease Control and Prevention. 2025-2026 Flu Season. Available at https://www.cdc.gov/flu/season/2025-2026.html#. Last accessed November 18, 2025.

55. Milián E, Kamen AA. Current and emerging cell culture manufacturing technologies for influenza vaccines. Biomed Res Int. 2015;2015:504831.

56. Medical News Today. Baxter Reveals Interim Results on Pandemic Flu Vaccine Clinical Trial. Available at https://www.medicalnewstoday.com/articles/66602#1. Last accessed November 18, 2025.

57. U.S. Food and Drug Administration. FDA Approves New Seasonal Influenza Vaccine Made Using Novel Technology. Available at https://wayback.archive-it.org/7993/20170111225529/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm335891.htm. Last accessed November 18, 2025.

58. Rojahn SY. Synthetic Biology Could Speed Flu Vaccine Production. Available at https://www.technologyreview.com/s/514661/synthetic-biology-could-speed-flu-vaccine-production. Last accessed November 18, 2025.

59. Edwards KM, Burns VE, Allen LM, et al. Eccentric exercise as an adjuvant to influenza vaccination in humans. Brain Behav Immun. 2007;21(2):209-217.

60. Kohut ML, Arntson BA, Lee W, et al. Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine. 2004;22(17-18):2298-2306.

61. LexiDrug. Available at https://online.lexi.com. Last accessed November 18, 2025.

62. Centers for Disease Control and Prevention. Update: recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010–11. MMWR. 2010;59(31):989-992.

63. Centers for Disease Control and Prevention. ACIP. Recommendations. Available at https://www.cdc.gov/acip/vaccine-recommendations/index.html. Last accessed November 18, 2025.

64. U.S. health officials call for vigilance against influenza: vaccine supplies predicted to be ample. Nation's Health. 2003;33(9).

65. Centers for Disease Control and Prevention. Inactivated Influenza Vaccine VIS. Available at https://www.cdc.gov/vaccines/hcp/current-vis/influenza-inactivated.html. Last accessed November 18, 2025.

66. Centers for Disease Control and Prevention. Getting a Flu Vaccine and Other Recommended Vaccines at the Same Time. Available at https://www.cdc.gov/flu/vaccines/coadministration.html#. Last accessed November 18, 2025.

67. Centers for Disease Control and Prevention. Weekly U.S. Influenza Surveillance Report: Key Updates for Week 38, Ending September 20, 2025. Available at https://www.cdc.gov/fluview/surveillance/week-38.html. Last accessed November 18, 2025.

68. Greenhawt M, Turner PJ, Kelso JM. Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017. Ann Allergy Asthma Immunol. 2018;120:49-52.

69. Ferdinands JM. Thompson MG, Blanton L, Spencer S, Grant L, Fry AM. Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine. 2021;39(28):3678-3695.

70. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR. 2005;55(RR8):1-40.

71. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR. 2008;57(RR7):1-60.

72. Daily Med. FluMist Quadrivalent (Influenza Vaccine Live Intranasal) Spray. Available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64f300d3-e1ba-40bc-a25f-4203ffdb27cf. Last accessed November 18, 2025.

73. Center for Infectious Disease Research and Policy. CDC Vaccine Panel Brings Back FluMist for 2018–19 Season. Available at http://www.cidrap.umn.edu/news-perspective/2018/02/cdc-vaccine-panel-brings-back-flumist-2018-19-season. Last accessed November 18, 2025.

74. Centers for Disease Control and Prevention. Interim Guidance on Influenza Antiviral Post-Exposure Prophylaxis of Persons Exposed to Birds or Other Animals with Novel Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease. Available at https://www.cdc.gov/bird-flu/hcp/clinicians-evaluating-patients/interim-guidance-post-exposure.html. Last accessed November 18, 2025.

75. U.S. Department of Health and Human Services. Healthy People 2030. Available at https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-people-who-get-flu-vaccine-every-year-iid-09. Last accessed November 18, 2025.

76. ICLAC. National Influenza Vaccination Week. Available at https://immunizelac.org/series/national-influenza-vaccination-week/. Last accessed November 18, 2025.

77. Centers for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2023-24 Influenza Season. Available at https://www.cdc.gov/fluvaxview/coverage-by-season/2023-2024.html. Last accessed November 18, 2025.

78. Centers for Disease Control and Prevention. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2023-24 Influenza Season. Available at https://www.cdc.gov/fluvaxview/coverage-by-season/health-care-personnel-coverage-2023-24.html. Last accessed November 18, 2025.

79. KFF. Flu Vaccination Rates for High-Risk Adults. Available at https://www.kff.org/state-health-policy-data/state-indicator/flu-vaccination-rates-for-high-risk-adults. last accessed November 18, 2025.

80. Caban-Martinez AJ, Lee DJ, Davila EP, et al. Sustained low influenza vaccination rates in US healthcare workers. Prev Med. 2010;50:210-212.

81. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46(4):398-412.

82. Centers for Disease Control and Prevention. Key Facts about Seasonal Flu Vaccine. Available at https://www.cdc.gov/flu/vaccines/keyfacts.html. Last accessed November 18, 2025.

83. Centers for Disease Control and Prevention. Healthcare Providers: Understanding Needle Fears and Phobia. Available at https://www.cdc.gov/disability-and-health/covid-19-resources/healthcare-providers-needle-phobia.html. Last accessed November 18, 2025.

84. Centers for Disease Control and Prevention. Flu Resource Center. Available at https://www.cdc.gov/flu-resources. Last accessed November 18, 2025.

85. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health care professionals. MMWR. 2006;55(RR2):1-16.

86. Bowser A. Vaccines Effective in Nursing Home Residents. Available at https://www.medscape.com/viewarticle/474119. Last accessed November 18, 2025.

87. Hennepin County Community Health Department. Infectious Diseases. Available at https://www.hennepin.us/childcaremanual. Last accessed November 18, 2025.

88. Centers for Disease Control and Prevention. Clean Hands: About Handwashing. Available at https://www.cdc.gov/clean-hands/about/index.html. Last accessed November 18, 2025.

89. Centers for Disease Control and Prevention. How Flu Spreads. Available at https://www.cdc.gov/flu/spread/index.html. Last accessed November 18, 2025.

90. Centers for Disease Control and Prevention. Healthy Habits to Prevent Flu. Available at https://www.cdc.gov/flu/prevention/actions-prevent-flu.html. Last accessed November 18, 2025.

91. Harvard Health Publishing. How to Boost Your Immune System. Available at https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system. Last accessed November 18, 2025.

92. Centers for Disease Control and Prevention. Infection Prevention and Control Strategies for Seasonal Influenza in Healthcare Settings. Available at https://www.cdc.gov/flu/hcp/infection-control/healthcare-settings.html. Last accessed November 18, 2025.

93. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011;60(RR1):1-24.

94. Centers for Disease Control and Prevention. Influenza Antiviral Medications: Summary for Clinicians. Available at https://www.cdc.gov/flu/hcp/antivirals/summary-clinicians.html. Last accessed November 18, 2025.

95. Editorial. New concerns about oseltamivir. Lancet. 2007;369(9567):1056.

96. Aoki FY, Allen UD, Stiver HG, Evans GA. The use of antiviral drugs for influenza: guidance for practitioners 2012/2013. Can J Infect Dis Med Microbiol. 2012;23(4):e79-e92.

97. Rothberg M, He S, Rose DN. Management of influenza symptoms in healthy adults: cost effectiveness of rapid testing and antiviral therapy. J Gen Intern Med. 2003;10(18):808-815.

98. Centers for Disease Control and Prevention. Treating Flu with Antiviral Drugs. Available at https://www.cdc.gov/flu/treatment/antiviral-drugs.html. Last accessed November 18, 2025.

99. U.S. Food and Drug Administration. Emergency Use Authorization of Peramivir IV: Fact Sheet for Health Care Providers. Available at https://www.fda.gov/media/77787/download. Last accessed November 18, 2025.

100. U.S. Food and Drug Administration. FDA Approves Rapivab to Treat Flu Infection. Available at https://wayback.archive-it.org/7993/20170111160835/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427755.htm. Last accessed November 18, 2025.

101. Drugs.com. Xofluza FDA Approval History. Available at https://www.drugs.com/history/xofluza.html#. Last accessed November 18, 2025.

102. Uyeki TM. A step forward in the treatment of influenza. N Engl J Med. 2018;379:975-977.

103. Centers for Disease Control and Prevention. Antiviral Drug Resistance among Influenza Viruses. Available at https://www.cdc.gov/flu/hcp/antivirals/antiviral-drug-resistance.html. Last accessed November 18, 2025.

104. Centers for Disease Control and Prevention. Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities. Available at https://www.cdc.gov/flu/hcp/infection-control/ltc-facility-guidance.html. Last accessed November 18, 2025.

105. Centers for Disease Control and Prevention. Flu-Related Questions and Answers by Topic. Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/about/flu-faq.htm. Last accessed November 18, 2025.

106. CDC Fact Sheet. Respiratory Hygiene/Cough Etiquette in Healthcare Settings. Available at https://ocde.us/EducationalServices/StudentInitiativesPartnershipsAndEvents/School-Safety/Documents/Pandemic_planning_tools_docs/cdcresphygiene.pdf. Last accessed November 18, 2025.

107. Centers for Disease Control and Prevention. Bird Flu: Causes and How it Spreads. Available at https://www.cdc.gov/bird-flu/virus-transmission. Last accessed November 18, 2025.

108. Tiensin T, Chaitaweesub P, Songserm T, et al. Highlyy pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis. 2005;11(11):1664-1672.

109. World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A(H5N1) Reported to WHO. Available at https://www.who.int/publications/m/item/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who--2003-2025--20-january-2025. Last accessed November 18, 2025.

110. Centers for Disease Control and Prevention. Highly Pathogenic Avian Influenza A (H5N1) in People (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/avianflu/h5n1-people.htm. Last accessed November 18, 2025.

111. Centers for Disease Control and Prevention. Global Summary of Recent Human Cases of H5N1 Bird Flu. Available at https://www.cdc.gov/bird-flu/spotlights/h5n1-summary-08042025.html. Last accessed November 18, 2025.

112. World Health Organization. Avian Influenza: Assessing the Pandemic Threat. Available at https://iris.who.int/server/api/core/bitstreams/62125dd4-b5fa-4bd3-b357-908fe4087660/content. Last accessed November 18, 2025.

113. Centers for Disease Control and Prevention. Public Health Threat of Highly Pathogenic Avian Influenza A (H5N1) Virus (Archive). Available at https://www.cdc.gov/flu/avianflu/h5n1-threat.htm. Last accessed November 18, 2025.

114. Centers for Disease Control and Prevention. H5 Bird Flu: Current Situation. Available at https://www.cdc.gov/bird-flu/situation-summary/index.html. Last accessed November 18, 2025.

115. Hitt E. Avian Flu: What Clinicians Need to Know. Available at https://www.medscape.com/viewarticle/468007. Last accessed November 18, 2025.

116. U.S. Department of Agriculture. USDA Avian Influenza Fact Sheet. Available at https://www.usda.gov/sites/default/files/documents/usda-avian-influenza-factsheet.pdf. Last accessed November 18, 2025.

117. World Health Organization. Frequently Asked Questions on Human Infection Caused by the Avian Influenza A(H7N9) Virus. Available at https://cdn.who.int/media/docs/default-source/influenza/avian-and-other-zoonotic-influenza/h7n9-background-information/faqs_influenza-ah7n9_14_feb_2014.pdf?sfvrsn=ca0321b6_5&download=true. Last accessed November 18, 2025.

118. Centers for Disease Control and Prevention. Influenza activity in the United States During the 2024-25 Season and Compositiion of the 2025-26 Influenza Vaccine. Available at https://www.cdc.gov/flu/whats-new/2025-2026-influenza-activity.html. Last accessed November 18, 2025.

119. Li C, Hatta M, Nidom CA, et al. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci USA. 2010;107(10):4687-4692.

120. Centers for Disease Control and Prevention. Guidelines for West Nile Virus Surveillance and Control. Available at https://www.cdc.gov/west-nile-virus/php/surveillance-and-control-guidelines/index.html. Last accessed November 18, 2025.

121. World Health Organization. Influenza A(H5N1) Highly Pathogenic Avian Influenza: Timeline of Major Events. Available at https://www.who.int/publications/m/item/influenza-a(h5n1)-highly-pathogenic-avian-influenza-timeline-of-major-events. Last accessed November 18, 2025.

122. Centers for Disease Control and Prevention. Outbreaks of North American Lineage Avian Influenza Viruses (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/avianflu/north-american-lineage.htm. Last accessed November 18, 2025.

123. Centers for Disease Control and Prevention. Preventing Bird Flu Infections. Available at https://www.cdc.gov/bird-flu/prevention. Last accessed November 18, 2025.

124. Centers for Disease Control and Prevention. CDC A(H5N1) Bird Flu Response Update February 26, 2025. Available at https://www.cdc.gov/bird-flu/spotlights/h5n1-response-02262025.html. Last accessed November 18, 2025.

125. Crispin SW, Cohen M, Mapes T. Bird-flu outbreak revives concerns stirred by SARS. Wall Street Journal. January 28, 2004. Available at https://www.wsj.com/articles/SB107524207391913268. Last accessed November 18, 2025.

126. National Institutes of Health. NIH Officials Assess Threat of H5N1. Available at https://www.nih.gov/news-events/news-releases/nih-officials-assess-threat-h5n1. Last accessed November 18, 2025.

127. Gamblin SJ, Haire LF, Russell RJ, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science. 2004;303(5665):1838-1842.

128. Centers for Disease Control and Prevention. Bird Infections with Highly-Pathogenic Avian Influenza A (H5N2), (H5N8), and (H5N1) Viruses: Recommendations for Human Health Investigations and Response. Available at https://stacks.cdc.gov/view/cdc/31362. Last accessed November 18, 2025.

129. Centers for Disease Control and Prevention. H5 Bird Flu: Current Situation. Available at https://www.cdc.gov/bird-flu/situation-summary. Last accessed November 18, 2025.

130. European Centre for Disease Prevention and Control. Avian Influenza Overview June–September 2025. Available at https://www.ecdc.europa.eu/en/publications-data/avian-influenza-overview-june-september-2025. Last accessed November 18, 2025.

131. Government of Canada. Status of Ongoing Avian Influenza Response by Province. Available at https://inspection.canada.ca/en/animal-health/terrestrial-animals/diseases/reportable/avian-influenza/latest-bird-flu-situation/status-ongoing-response. Last accessed November 18, 2025.

132. Center for Infectious Disease Research and Policy. WHO Changes H5N1 Strains for Pandemic Vaccines, Raising Concern Over Virus Evolution. Available at https://www.cidrap.umn.edu/news-perspective/2006/08/who-changes-h5n1-strains-pandemic-vaccines-raising-concern-over-virus. Last accessed November 18, 2025.

133. GlaxoSmithKline. GlaxoSmithKline Receives New HHS Order. Available at https://www.biopharminternational.com/view/glaxosmithkline-receives-new-hhs-order. Last accessed November 18, 2025.

134. U.S. Food and Drug Administration. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Manufactured by ID Biomedical Corporation – Questions and Answers. Available at https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/influenza-h5n1-virus-monovalent-vaccine-adjuvanted-manufactured-id-biomedical-corporation-questions. Last accessed November 18, 2025.

135. International Federation of Pharmaceutical Manufacturers and Associations. IFPMA Supports Principles of Pandemic Influenza Preparedness Decision. Available at https://www.ifpma.org/resource-centre/ifpma-supports-principles-of-pandemic-influenza-preparedness-decision. Last accessed November 18, 2025.

136. U.S. Food and Drug Administration. FDA Approves First U.S. Vaccine for Humans against the Avian Influenza Virus H5N1. Available at https://wayback.archive-it.org/7993/20170112213127/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108892.htm. Last accessed November 18, 2025.

137. U.S. Department of Health and Human Services. FDA Approves First Adjuvanted Vaccine for Prevention of H5N1 Avian Influenza. Available at https://wayback.archive-it.org/7993/20170111161026/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376444.htm. Last accessed November 18, 2025.

138. He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet. 1999;37(6):471-484.

139. Kirkey S. Bird flu could kill 50,000 in Canada. Ottawa Citizen. January 30, 2004.

140. World Health Organization. One Health Intelligence (OHI). Available at https://cdn.who.int/media/docs/default-source/crs-crr/glews-epiwin-28nov2024_final.pdf?sfvrsn=883ac6cd_1. Last accessed November 18, 2025.

141. World Organization for Animal Health. Avian Influenza. Available at https://www.woah.org/en/disease/avian-influenza/. Last accessed November 18, 2025.

142. Altman LK. As bird flu spreads global health weaknesses are exposed. New York Times. February 3, 2004. Available at https://www.nytimes.com/2004/02/03/health/the-doctor-s-world-as-bird-flu-spreads-global-health-weaknesses-are-exposed.html?pagewanted=all&src=pm. Last accessed November 18, 2025.

143. Centers for Disease Control and Prevention. Guidelines and Recommendations: Interim Guidance about Avian Influenza (H5N1) for U.S. Citizens Living Abroad. Available at https://wwwnc.cdc.gov/travel/page/avian-flu-americans-abroad. Last accessed November 18, 2025.

144. U.S. Department of Transportation. Federal Aviation Administration. Safety Alert for Operators. Avian Influenza (AKA, avian flu, bird flu) – Current Information for Crewmembers. Available at https://www.faa.gov/sites/faa.gov/files/other_visit/aviation_industry/airline_operators/airline_safety/safo_05006.pdf. Last accessed November 18, 2025.

145. CDC Swine Influenza Guidance. Interim Guidance for Airline Flight Crews Arriving from Areas Affected by Swime Influenza. Available at https://www2.alpa.org/DesktopModules/ALPA_Documents/ALPA_DocumentsView.aspx?itemid=18627&ModuleId=2044&Tabid=256. Last accessed November 18, 2025.

146. Centers for Disease Control and Prevention. Collecting Specimens for Novel Influenza A Virus Testing. Available at https://www.cdc.gov/bird-flu/hcp/clinicians-evaluating-patients/specimen-collection.html. Last accessed November 18, 2025.

147. California Department of Public Health. Avian Influenza A(H5N1). Information for Health Professionals. Available at https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/BirdFluHP.aspx. Last accessed November 18, 2025.

148. Centers for Disease Control and Prevention. Influenza Division International Program (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/international/program/index.htm. Last accessed November 18, 2025.

149. Centers for Disease Control and Prevention. Key Facts about Human Infections with Variant Viruses (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/swineflu/keyfacts-variant.htm. Last accessed November 18, 2025.

150. World Health Organization. Avian Influenza Update: Implications of H5N1 Infections in Pigs in China. Available at https://www.who.int/emergencies/disease-outbreak-news/item/2004_08_25-en. Last accessed November 18, 2025.

151. Centers for Disease Control and Prevention. About Swine/Variant Flu. Available at https://www.cdc.gov/swine-flu/about/index.html#. Last accessed November 18, 2025.

152. Centers for Disease Control and Prevention. Swine Flu Prevention and People Who Raise Pigs. Available at https://www.cdc.gov/swine-flu/risk-factors/index.html. Last accessed November 18, 2025.

153. Centers for Disease Control and Prevention. 2009 H1N1 Flu ("Swine Flu") and You. Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/h1n1flu/qa.htm. Last accessed November 18, 2025.

154. Centers for Disease Control and Prevention. The 2009 H1N1 Pandemic: Summary highlights, April 2009–April 2010 (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/h1n1flu/cdcresponse.htm. Last accessed November 18, 2025.

155. Centers for Disease Control and Prevention. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009–2010 Season (Archive). Available at https://www.cdc.gov/h1n1flu/recommendations.htm. Last accessed November 18, 2025.

156. World Health Organization. H1N1 in Post-Pandemic Period. Available at https://www.who.int/news/item/10-08-2010-h1n1-in-post-pandemic-period. Last accessed November 18, 2025.

157. Centers for Disease Control and Prevention. Preventing Seasonal Flu. Available at https://www.cdc.gov/flu/prevention. Last accessed November 18, 2025.

158. Lau JTF, Griffiths S, Choi K-C, Lin C. Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control. 2010;38(5):374-380.

159. Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices, 2009. MMWR. 2009;58(RR10):1-8.

160. Centers for Disease Control and Prevention. Signs and Symptoms of Flu. Available at https://www.cdc.gov/flu/signs-symptoms. Last accessed November 18, 2025.

161. Centers for Disease Control and Prevention. Influenza Signs and Symptoms and the Role of Laboratory Diagnostics (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/professionals/diagnosis/labrolesprocedures.htm. Last accessed November 18, 2025.

162. Centers for Disease Control and Prevention. New CDC Test to Detect Human Infections with the 2009 H1N1 Influenza Virus Authorized for Use by FDA (Archive). Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/pressrel/2010/r100622.htm. Last accessed November 18, 2025.

163. Centers for Disease Control and Prevention. Information on Rapid Molecular Assays, RT-PCR, and Other Molecular Assays for Diagnosis of Influenza Virus Infection. Available at https://www.cdc.gov/flu/hcp/testing-methods/molecular-assays.html. Last accessed November 18, 2025.

164. World Health Organization. Clinical Practice Guidelines for Influenza. Available at https://www.who.int/publications/i/item/9789240097759. Last accessed November 18, 2025.

165. U.S. Food and Drug Administration. FDA Public Health Alert: Potential Medication Errors with Tamiflu for Oral Suspension. Available at https://wayback.archive-it.org/7993/20170723103955/https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm183649.htm. Last accessed November 18, 2025.

166. Sousa TDC, Martins JSCC, Miranda MD, et al. Low prevalence of influenza A strains with resistance markers in Brazil during 2017–2019 seasons. Front Public Health. 2022;10:944277.

167. O'Neill G, Aziz A, Kuba M, et al. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020–2021. Commun Dis Intell (2018). 2022;46:10.33321.

168. National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press; 2022.

169. U.S. Department of Veterans Affairs. Pandemic Flu. Available at https://www.prevention.va.gov/flu/pandemic/index.asp. Last accessed November 18, 2025.

170. Centers for Disease Control and Prevention. Influenza (Flu). Available at https://www.cdc.gov/flu/index.htm. Last accessed November 18, 2025.

171. World Health Organization. WHO Checklist for Influenza Pandemic Preparedness Planning. Geneva: World Health Organization, Department of Communicable Disease, Surveillance and Response, Global Influenza Programme; 2005.

172. Hearne SA, Davis M, Segal LM, et al. Ready or not? Protecting the public's health in the age of bioterrorism. Biosecur Bioterror. 2004;2(1):47-50.

173. World Health Organization. Pandemic Influenza Risk Management: A WHO guide to inform and harmonize national and international pandemic preparedness and response. Geneva: World Health Organization; 2017.

174. Centers for Disease Control and Prevention. Interim Guidance for the Use of Masks to Control Seasonal Influenza Virus Transmission. Available at https://www.cdc.gov/flu/hcp/infection-control/mask-guidance.html. Last accessed November 18, 2025.

175. Centers for Disease Control and Prevention. National Pandemic Strategy. Available at https://www.cdc.gov/pandemic-flu/php/national-strategy/. Last accessed November 18, 2025.

176. U.S. Department of Health and Human Services. Pandemic Influenza Plan: 2017 Update. Available at https://www.cdc.gov/pandemic-flu/media/pan-flu-report-2017v2.pdf. Last accessed November 18, 2025.

177. Centers for Disease Control and Prevention. CDC's World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology and Control of Influenza. Available at https://www.cdc.gov/flu/php/who-collaboration. Last accessed November 18, 2025.

178. Gensheimer KF, Meltzer MI, Postema AS, Strikas RA. Influenza pandemic preparedness. Emerg Infect Dis. 2003;9(12):1645-1648.

179. California Emergency Medical Services Agency. Shelter Medical Group Toolkit: Local Emergency Preparedness Planners Guide for the Care and Sheltering of the Medically Fragile. Available at https://emsa.ca.gov/wp-content/uploads/sites/71/2017/07/TOOLKIT.pdf. Last accessed November 18, 2025.

180. Federal Emergency Management Agency. Incident management. Available at https://www.ready.gov/business/resources/incident-management. Last accessed November 18, 2025.

181. U.S. Chamber of Commerce. How to Keep America Safe and Open. Available at https://www.uschamber.com/economy/how-keep-america-safe-and-open-0. Last accessed November 18, 2025.

182. Bakalar N. How (and How Not) to Battle Flu: a Tale of 23 Cities. The New York Times. April 17, 2007. Available at https://www.nytimes.com/2007/04/17/health/17flu.html. Last accessed November 18, 2025.

183. Centers for Disease Control and Prevention. Ethical Guidelines in Pandemic Influenza: Recommendations of the Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention. Available at https://www.cdc.gov/scientific-integrity/media/pdfs/2024/10/panflu_ethic_guidelines.pdf. Last accessed November 18, 2025.

184. Markel H, Lipman HB, Navarro JA, et al. Nonpharmaceutical interventions implemented by U.S. cities during the 1918–1919 influenza pandemic. JAMA. 2007;298(6):644-654.

185. New York City Department of Health and Mental Hygiene. NYC DOHMH Pandemic Influenza Preparedness and Response Plan. Available at https://www1.nyc.gov/assets/em/downloads/pdf/hazard_mitigation/nycs_risk_landscape_chapter_4.9_pandemic_flu.pdf. Last accessed November 18, 2025.

186. Oral report from L. Bennett, member of the summer 2007 Azusa Pacific University research team.

187. Leighty J. Code zebra: on the frontlines, California EDs brace for action against infectious disease and bioterrorism. Nurse Week. 2004;13-15.

188. Sachs JD, Karim SSA, Aknin L, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400(10359):1224-1280.